OptiBiotix Health (LON:OPTI) Trading Up 17.2% – What’s Next?

OptiBiotix Health Plc (LON:OPTI)’s stock price traded up 17.2% during mid-day trading on Wednesday . The stock traded as high as GBX 7.50 and last traded at GBX 7.50. 1,127,499 shares traded hands during mid-day trading, an increase of 91% from the average session volume of 591,546 shares. The stock had previously closed at GBX 6.40.

OptiBiotix Health Stock Up 21.7%

The business has a fifty day moving average of GBX 7.05 and a 200 day moving average of GBX 9.21. The firm has a market cap of £8.05 million, a P/E ratio of -259.67 and a beta of 1.71.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.